Site-specific PEGylation of native disulfide bonds in therapeutic proteins
Authors:
- 23 April 2006
- journal article
- Published by Springer Nature in Nature Chemical Biology
- Vol. 2 (6) , 312-313
Abstract
Nature - the world's best science and medicine on your desktopKeywords
This publication has 10 references indexed in Scilit:
- Site of Pegylation and Polyethylene Glycol Molecule Size Attenuate Interferon-α Antiviral and Antiproliferative Activities through the JAK/STAT Signaling PathwayJournal of Biological Chemistry, 2005
- Replacement of the interchain disulfide bridge-forming amino acids A7 and B7 by glutamate impairs the structure and activity of insulinBiological Chemistry, 2004
- Effect of pegylation on pharmaceuticalsNature Reviews Drug Discovery, 2003
- Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis CAdvanced Drug Delivery Reviews, 2002
- Structural and Biologic Characterization of Pegylated Recombinant IFN- α 2bJournal of Interferon & Cytokine Research, 2001
- Rational Design of a Potent, Long-Lasting Form of Interferon: A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis CBioconjugate Chemistry, 2001
- Disulfide Bonds and Protein FoldingBiochemistry, 2000
- Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding.Journal of Experimental Medicine, 1990
- Site-directed chemical modification and crosslinking of a monoclonal antibody using equilibrium transfer alkylating crosslink reagentsBioconjugate Chemistry, 1990
- Molecular yardsticks. Synthesis of extended equilibrium transfer alkylating cross-link reagents and their use in the formation of macrocyclesJournal of the American Chemical Society, 1988